Back to UBS Group AG UBS Group AG

KPRXKPRX
Showing 8 of 9 quarters

Position history for UBS Group AGUBS Group AG's holdings in KIORA PHARMACEUTICALS INC

Yes. Ubs holds 1,961 shares of KPRX (Kiora Pharmaceuticals), worth $5,157, as of its Q2 2026 13F filing. It increased the position by 660 shares (+50.7%) from Q1 2026. Ubs has held KPRX since Q2 2024, across 9 quarterly 13F filings.

Current Value

$5,157

Current Shares

1,961

Total Value Change

+$3,862

Total Shares Change

+1,607

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1,961
+50.7%
$5,1570.0%$2.63
14
2026-Q1
Increased
1,301
+42.6%
$2,5110.0%$1.93
11
2025-Q4
Decreased
912
-33.1%
$1,7970.0%$1.97
0
2025-Q3
Decreased
1,364
-92.3%
$3,7920.0%$2.78
0
2025-Q2
Increased
17,644
+8821x
$50,8150.0%$2.88
23
2025-Q1
Unchanged
2
0.0%
$60.0%$3.01
0
2024-Q4
Decreased
2
-99.4%
$70.0%$3.30
0
2024-Q3
Decreased
354
-95.8%
$1,2950.0%$3.66
0

Other major holders of KPRX: Alyeska Investment Group, L.P., CITADEL ADVISORS LLC, TWO SIGMA INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used